Sun Pharm Industries patents expiration

1. Ultravate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962028 SUN PHARM INDUSTRIES Topical steroid composition and method
Jun, 2033

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) Aug 31, 2023

Drugs and Companies using HALOBETASOL PROPIONATE ingredient

Market Authorisation Date: 06 November, 2015

Treatment: Use of a lotion containing halobetasol propionate for the treatment of corticosteroid-responsive dermatoses including psoriasis


How can I launch a generic of ULTRAVATE before it's drug patent expiration?
More Information on Dosage

ULTRAVATE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic